| 1 | RASSF1, YAP1
|
| RASSF1A uncouples Wnt from Hippo signalling and promotes YAP mediated differentiation via p73.
|
| Papaspyropoulos A, Bradley L, Thapa A, Leung CY, Toskas K, Koennig D, Pefani DE, Raso C, Grou C, Hamilton G, Vlahov N, Grawenda A, Haider S, Chauhan J, Buti L, Kanapin A, Lu X, Buffa F, Dianov G, von Kriegsheim A, Matallanas D, Samsonova A, Zernicka-Goetz M, O'Neill E.
|
| Nat Commun 9(1):424. doi: 10.1038/s41467-017-02786-5.
2018
|
| 2 | ANKRD1, RASSF1, YAP1
|
| The tumor suppressor RASSF1A induces the YAP1 target gene ANKRD1 that is epigenetically inactivated in human cancers and inhibits tumor growth.
|
| Jiménez AP, Traum A, Boettger T, Hackstein H, Richter AM, Dammann RH.
|
| Oncotarget 8(51):88437-88452. doi: 10.18632/oncotarget.18177. eCollection 2017 Oct 24.
2017
|
| 3 | RASSF1
|
| Frequent silencing of RASSF1A by DNA methylation in thymic neuroendocrine tumours.
|
| Kajiura K, Takizawa H, Morimoto Y, Masuda K, Tsuboi M, Kishibuchi R, Wusiman N, Sawada T, Kawakita N, Toba H, Yoshida M, Kawakami Y, Naruto T, Imoto I, Tangoku A, Kondo K.
|
| Lung Cancer 111:116-123. doi: 10.1016/j.lungcan.2017.05.019. Epub 2017 May 25.
2017
|
| 4 | RASSF1, YAP1
|
| TGF-β Targets the Hippo Pathway Scaffold RASSF1A to Facilitate YAP/SMAD2 Nuclear Translocation.
|
| Pefani DE, Pankova D, Abraham AG, Grawenda AM, Vlahov N, Scrace S, O' Neill E.
|
| Mol Cell 63(1):156-66. doi: 10.1016/j.molcel.2016.05.012. Epub 2016 Jun 9.
2016
|
| 5 | RASSF1, RHEB
|
| Rheb may complex with RASSF1A to coordinate Hippo and TOR signaling.
|
| Nelson N, Clark GJ.
|
| Oncotarget 7(23):33821-31. doi: 10.18632/oncotarget.8447.
2016
|
| 6 | BRCA2, RASSF1
|
| Safeguarding genome stability: RASSF1A tumor suppressor regulates BRCA2 at stalled forks.
|
| Pefani DE, O'Neill E.
|
| Cell Cycle 14(11):1624-30. doi: 10.1080/15384101.2015.1035845.
2015
|
| 7 | PRMT5, RASSF1
|
| Identification of protein arginine N-methyltransferase 5 (PRMT5) as a novel interacting protein with the tumor suppressor protein RASSF1A.
|
| Sakai N, Saito Y, Fujiwara Y, Shiraki T, Imanishi Y, Koshimizu TA, Shibata K.
|
| Biochem Biophys Res Commun 467(4):778-84. doi: 10.1016/j.bbrc.2015.10.065. Epub 2015 Oct 20.
2015
|
| 8 | BAX, MOAP1, RASSF1
|
| Modulator of apoptosis 1 (MOAP-1) is a tumor suppressor protein linked to the RASSF1A protein.
|
| Law J, Salla M, Zare A, Wong Y, Luong L, Volodko N, Svystun O, Flood K, Lim J, Sung M, Dyck JR, Tan CT, Su YC, Yu VC, Mackey J, Baksh S.
|
| J Biol Chem 290(40):24100-18. doi: 10.1074/jbc.M115.648345. Epub 2015 Aug 12.
2015
|
| 9 | RASSF1, XPA
|
| The RASSF1A tumor suppressor regulates XPA-mediated DNA repair.
|
| Donninger H, Clark J, Rinaldo F, Nelson N, Barnoud T, Schmidt ML, Hobbing KR, Vos MD, Sils B, Clark GJ.
|
| Mol Cell Biol 35(1):277-87. doi: 10.1128/MCB.00202-14. Epub 2014 Nov 3.
2015
|
| 10 | RASSF1
|
| Cell cycle restriction is more important than apoptosis induction for RASSF1A protein tumor suppression.
|
| Donninger H, Clark JA, Monaghan MK, Schmidt ML, Vos M, Clark GJ.
|
| J Biol Chem 289(45):31287-95. doi: 10.1074/jbc.M114.609537. Epub 2014 Sep 15.
2014
|
| 11 | RASSF1
|
| The tumour suppressor Ras-association domain family protein 1A (RASSF1A) regulates TNF-α signalling in cardiomyocytes.
|
| Mohamed TM, Zi M, Prehar S, Maqsood A, Abou-Leisa R, Nguyen L, Pfeifer GP, Cartwright EJ, Neyses L, Oceandy D.
|
| Cardiovasc Res 103(1):47-59. doi: 10.1093/cvr/cvu111. Epub 2014 Apr 28.
2014
|
| 12 | RASSF1
|
| Microtubule segment stabilization by RASSF1A is required for proper microtubule dynamics and Golgi integrity.
|
| Arnette C, Efimova N, Zhu X, Clark GJ, Kaverina I.
|
| Mol Biol Cell 25(6):800-10. doi: 10.1091/mbc.E13-07-0374. Epub 2014 Jan 29.
2014
|
| 13 | DAXX, RASSF1
|
| Methylation of RASSF1A gene promoter is regulated by p53 and DAXX.
|
| Zhang H, He J, Li J, Tian D, Gu L, Zhou M.
|
| FASEB J 27(1):232-42. doi: 10.1096/fj.12-215491. Epub 2012 Oct 4.
2013
|
| 14 | CTDSPL, RASSF1
|
| Novel tumor suppressor candidates on chromosome 3 revealed by NotI-microarrays in cervical cancer
|
| Senchenko VN, Kisseljova NP, Ivanova TA, Dmitriev AA, Krasnov GS, Kudryavtseva AV, Panasenko GV, Tsitrin EB, Lerman MI, Kisseljov FL, Kashuba VI, Zabarovsky ER.
|
| Epigenetics. Apr;8(4):409-20. doi: 10.4161/epi.24233. Epub 2013 Mar 11. 2013
|
| 15 | RASSF1
|
| RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development.
|
| Thaler S, Schmidt M, Schad A, Sleeman JP.
|
| Oncogene 31(47):4912-22. doi: 10.1038/onc.2011.658. Epub 2012 Jan 23.
2012
|
| 16 | RASSF1, STK3, STK4
|
| The tumor suppressor RASSF1A prevents dephosphorylation of the mammalian STE20-like kinases MST1 and MST2.
|
| Guo C, Zhang X, Pfeifer GP.
|
| J Biol Chem 286(8):6253-61. Epub 2011 Jan 3.
2011
|
| 17 | RASSF1
|
| RASSF1A suppresses the activated K-Ras-induced oxidative DNA damage.
|
| Park SH, Kim JJ, Chung JS, Lee SR, Lee GY, Kim HJ, Yoo YD.
|
| Biochem Biophys Res Commun 408(1):149-53. Epub 2011 Apr 5.
2011
|
| 18 | CDC20, RASSF1
|
| Regulation of APC/C(Cdc20) activity by RASSF1A-APC/C(Cdc20) circuitry.
|
| Chow C, Wong N, Pagano M, Lun SW, Nakayama KI, Nakayama K, Lo KW.
|
| Oncogene ncogene. 2011 Aug 29. doi: 10.1038/onc.2011.372. [Epub ahead of print]
2011
|
| 19 | RASSF1, SAV1
|
| Salvador protein is a tumor suppressor effector of RASSF1A with hippo pathway-independent functions.
|
| Donninger H, Allen N, Henson A, Pogue J, Williams A, Gordon L, Kassler S, Dunwell T, Latif F, Clark GJ.
|
| J Biol Chem 286(21):18483-91. Epub 2011 Apr 13.
2011
|
| 20 | RAP1A, RASSF1
|
| The tumor suppressor RASSF1A is a novel effector of small G protein Rap1A.
|
| Verma SK, Ganesan TS, Kishore U, Parker PJ.
|
| Protein Cell 2(3):237-49. doi: 10.1007/s13238-011-1028-z. Epub 2011 Apr 6.
2011
|
| 21 | RASSF1
|
| Dual role of RASSF1 as a tumor suppressor and an oncogene in neuroendocrine tumors of the lung.
|
| Pelosi G, Fumagalli C, Trubia M, Sonzogni A, Rekhtman N, Maisonneuve P, Galetta D, Spaggiari L, Veronesi G, Scarpa A, Malpeli G, Viale G.
|
| Anticancer Res 30(10):4269-81.
2010
|
| 22 | RASSF1
|
| Frequent promoter hypermethylation of the APC and RASSF1A tumour suppressors in parathyroid tumours.
|
| Juhlin CC, Kiss NB, Villablanca A, Haglund F, Nordenström J, Höög A, Larsson C.
|
| PLoS One 5(3):e9472.
2010
|
| 23 | RASSF1
|
| Functional importance of RASSF1A microtubule localization and polymorphisms.
|
| El-Kalla M, Onyskiw C, Baksh S.
|
| Oncogene 29(42):5729-40. Epub 2010 Aug 9.
2010
|
| 24 | RASSF1, RASSF10, RASSF2, RASSF3, RASSF4, RASSF5, RASSF6, RASSF7, RASSF8, RASSF9
|
| The RASSF proteins in cancer; from epigenetic silencing to functional characterization.
|
| Richter AM, Pfeifer GP, Dammann RH.
|
| Biochim Biophys Acta 1796(2):114-28. Epub 2009 Mar 31. Review.PMID: 19344752 2009
|
| 25 | AURKB, RASSF1, STX16
|
| Aurora B-mediated phosphorylation of RASSF1A maintains proper cytokinesis by recruiting Syntaxin16 to the midzone and midbody.
|
| Song SJ, Kim SJ, Song MS, Lim DS.
|
| Cancer Res 69(22):8540-4. Epub 2009 Nov 3.PMID: 19887622 2009
|
| 26 | RASSF1
|
| ATM regulates a RASSF1A-dependent DNA damage response.
|
| Hamilton G, Yee KS, Scrace S, O'Neill E.
|
| Curr Biol 19(23):2020-5. Epub 2009 Dec 3.
2009
|
| 27 | RASSF1, RASSF5
|
| NORE1B is a putative tumor suppressor in hepatocarcinogenesis and may act via RASSF1A.
|
| Macheiner D, Gauglhofer C, Rodgarkia-Dara C, Grusch M, Brachner A, Bichler C, Kandioler D, Sutterlüty H, Mikulits W, Schulte-Hermann R, Grasl-Kraupp B.
|
| Cancer Res 69(1):235-42.
2009
|
| 28 | RASSF1, RASSF5
|
| The growth and tumor suppressors NORE1A and RASSF1A are targets for calpain-mediated proteolysis.
|
| Kuznetsov S, Khokhlatchev AV.
|
| PLoS One 3(12):e3997. Epub 2008 Dec 22.
2008
|
| 29 | AURKA, RASSF1
|
| RASSF1A interacts with and activates the mitotic kinase Aurora-A.
|
| Liu L, Guo C, Dammann R, Tommasi S, Pfeifer GP.
|
| Oncogene 27(47):6175-86. Epub 2008 Jul 21.
2008
|
| 30 | MOAP1, RASSF1
|
| Dynamics of RASSF1A/MOAP-1 association with death receptors.
|
| Foley CJ, Freedman H, Choo SL, Onyskiw C, Fu NY, Yu VC, Tuszynski J, Pratt JC, Baksh S.
|
| Mol Cell Biol 28(14):4520-35. Epub 2008 May 12.
2008
|
| 31 | RASSF1, TRF3
|
| Latent membrane protein 1 suppresses RASSF1A expression, disrupts microtubule structures and induces chromosomal aberrations in human epithelial cells.
|
| Man C, Rosa J, Lee LT, Lee VH, Chow BK, Lo KW, Doxsey S, Wu ZG, Kwong YL, Jin DY, Cheung AL, Tsao SW.
|
| Oncogene 26(21):3069-80. Epub 2006 Nov 13.
2007
|
| 32 | RASSF1, RASSF10, RASSF2, RASSF3, RASSF4, RASSF5, RASSF6, RASSF7, RASSF8, RASSF9
|
| The Ras-association domain family (RASSF) members and their role in human tumourigenesis.
|
| van der Weyden L, Adams DJ.
|
| Biochim Biophys Acta 1776(1):58-85. Epub 2007 Jul 4. Review.PMID: 17692468 2007
|
| 33 | RASSF1
|
| Hypermethylation of the Ras association domain family 1A (RASSF1A) gene in gallbladder cancer.
|
| Kee SK, Lee JY, Kim MJ, Lee SM, Jung YW, Kim YJ, Park JY, Bae HI, Hong HS, Yun YK, Kim SG, Kim DS.
|
| Mol Cells 24(3):364-71.PMID: 18182852 2007
|
| 34 | EMC2, MSL1, PRPF3, RASSF1
|
| Characterization of hampin/MSL1 as a node in the nuclear interactome.
|
| Dmitriev RI, Korneenko TV, Bessonov AA, Shakhparonov MI, Modyanov NN, Pestov NB.
|
| Biochem Biophys Res Commun 355(4):1051-7. Epub 2007 Feb 23.
2007
|
| 35 | RASSF1
|
| Single nucleotide polymorphism at codon 133 of the RASSF1 gene is preferentially associated with human lung adenocarcinoma risk.
|
| Kanzaki H, Hanafusa H, Yamamoto H, Yasuda Y, Imai K, Yano M, Aoe M, Shimizu N, Nakachi K, Ouchida M, Shimizu K.
|
| Cancer Lett 238(1):128-34. Epub 2005 Aug 25. 2006
|
| 36 | RASSF1, DAXX
|
| Release of RASSF1C from the nucleus by Daxx degradation links DNA damage and SAPK/JNK activation.
|
| Kitagawa D, Kajiho H, Negishi T, Ura S, Watanabe T, Wada T, Ichijo H, Katada T, Nishina H.
|
| EMBO J 25(14):3286-97. Epub 2006 Jun 29. 2006
|
| 37 | RASSF1, STK4
|
| Role of the tumor suppressor RASSF1A in Mst1-mediated apoptosis.
|
| Oh HJ, Lee KK, Song SJ, Jin MS, Song MS, Lee JH, Im CR, Lee JO, Yonehara S, Lim DS.
|
| Cancer Res 66(5):2562-9.
2006
|
| 38 | BAX, KRAS, MOAP1, RASSF1
|
| The RASSF1A tumor suppressor activates Bax via MOAP-1.
|
| Vos MD, Dallol A, Eckfeld K, Allen NP, Donninger H, Hesson LB, Calvisi D, Latif F, Clark GJ.
|
| J Biol Chem 281(8):4557-63. Epub 2005 Dec 12.
2006
|
| 39 | RASSF1, ZMYND10
|
| Hypermethylation of RASSF1A and BLU tumor suppressor genes in non-small cell lung cancer: implications for tobacco smoking during adolescence.
|
| Marsit CJ, Kim DH, Liu M, Hinds PW, Wiencke JK, Nelson HH, Kelsey KT.
|
| Int J Cancer 114(2):219-23. 2005
|
| 40 | RASSF1, MAP1S
|
| The centrosomal protein RAS association domain family protein 1A (RASSF1A)-binding protein 1 regulates mitotic progression by recruiting RASSF1A to spindle poles.
|
| Song MS, Chang JS, Song SJ, Yang TH, Lee H, Lim DS.
|
| J Biol Chem 280(5):3920-7. Epub 2004 Nov 16. 2005
|
| 41 | MAP1S, LRPPRC, RASSF1
|
| Putative tumor suppressor RASSF1 interactive protein and cell death inducer C19ORF5 is a DNA binding protein.
|
| Liu L, Vo A, Liu G, McKeehan WL.
|
| Biochem Biophys Res Commun 332(3):670-6. 2005
|
| 42 | SEMA3B, RASSF1
|
| Allele loss and epigenetic inactivation of 3p21.3 in malignant liver tumors.
|
| Tischoff I, Markwarth A, Witzigmann H, Uhlmann D, Hauss J, Mirmohammadsadegh A, Wittekind C, Hengge UR, Tannapfel A.
|
| Int J Cancer 115(5):684-9. 2005
|
| 43 | RASSF1
|
| Promoter methylation of p16INK4a, RASSF1A, and DAPK is frequent in salivary adenoid cystic carcinoma.
|
| Li J, El-Naggar A, Mao L.
|
| Cancer 104(4):771-6. 2005
|
| 44 | RASSF1
|
| Involvement of the RASSF1A tumor suppressor gene in controlling cell migration.
|
| Dallol A, Agathanggelou A, Tommasi S, Pfeifer GP, Maher ER, Latif F.
|
| Cancer Res. 65(17):7653-9. 2005
|
| 45 | RASSF1
|
| Tumor susceptibility of Rassf1a knockout mice.
|
| Tommasi S, Dammann R, Zhang Z, Wang Y, Liu L, Tsark WM, Wilczynski SP, Li J, You M, Pfeifer GP.
|
| Cancer Res 65(1):92-8. 2005
|
| 46 | MOAP1, RASSF1
|
| The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to Bax conformational change and cell death.
|
| Baksh S, Tommasi S, Fenton S, Yu VC, Martins LM, Pfeifer GP, Latif F, Downward J, Neel BG.
|
| Mol Cell 18(6):637-50.
2005
|
| 47 | RASSF1, CDC20, FBXO5
|
| RASSF1A, the new guardian of mitosis.
|
| Mathe E.
|
| Nat Genet 36(2):117-8. No abstract available. 2004
|
| 48 | RASSF1
|
| The scaffold protein CNK1 interacts with the tumor suppressor RASSF1A and augments RASSF1A-induced cell death.
|
| Rabizadeh S, Xavier RJ, Ishiguro K, Bernabeortiz J, Lopez-Ilasaca M, Khokhlatchev A, Mollahan P, Pfeifer GP, Avruch J, Seed B.
|
| J Biol Chem 279(28):29247-54. Epub 2004 Apr 9. 2004
|
| 49 | RASSF1, ATP2B4
|
| Novel functional interaction between the plasma membrane Ca2+ pump 4b and the proapoptotic tumor suppressor Ras-associated factor 1 (RASSF1).
|
| Armesilla AL, Williams JC, Buch MH, Pickard A, Emerson M, Cartwright EJ, Oceandy D, Vos MD, Gillies S, Clark GJ, Neyses L.
|
| J Biol Chem 279(30):31318-28. Epub 2004 May 15. 2004
|
| 50 | MGMT, RASSF1
|
| Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours.
|
| Honorio S, Agathanggelou A, Wernert N, Rothe M, Maher ER, Latif F.
|
| Oncogene 22(3):461-6. 2003
|
| 51 | RASSF1
|
| Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers.
|
| Yu MY, Tong JH, Chan PK, Lee TL, Chan MW, Chan AW, Lo KW, To KF.
|
| Int J Cancer 105(2):204-9. 2003
|
| 52 | RASSF1
|
| Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma.
|
| Dammann R, Schagdarsurengin U, Liu L, Otto N, Gimm O, Dralle H, Boehm BO, Pfeifer GP, Hoang-Vu C.
|
| Oncogene 22(24):3806-12. 2003
|
| 53 | RASSF1
|
| RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication.
|
| Endoh H, Yatabe Y, Shimizu S, Tajima K, Kuwano H, Takahashi T, Mitsudomi T.
|
| Int J Cancer 106(1):45-51. 2003
|
| 54 | RASSF1
|
| Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer.
|
| Kim DH, Kim JS, Ji YI, Shim YM, Kim H, Han J, Park J.
|
| Cancer Res 63(13):3743-6. 2003
|
| 55 | RASSF1, FHIT, VHL, FHIT, RARB
|
| Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma.
|
| Kuroki T, Trapasso F, Yendamuri S, Matsuyama A, Alder H, Mori M, Croce CM.
|
| Cancer Res 63(13):3724-8. 2003
|
| 56 | RASSF1
|
| Epigenetic inactivation of RASSF1A candidate tumor suppressor gene at 3p21.3 in brain tumors.
|
| Horiguchi K, Tomizawa Y, Tosaka M, Ishiuchi S, Kurihara H, Mori M, Saito N.
|
| Oncogene 22(49):7862-5. 2003
|
| 57 | RASSF1, TSG3B
|
| Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo.
|
| Ji L, Nishizaki M, Gao B, Burbee D, Kondo M, Kamibayashi C, Xu K, Yen N, Atkinson EN, Fang B, Lerman MI, Roth JA, Minna JD.
|
| Cancer Res 62(9):2715-20. 2002
|
| 58 | RASSF1, KRAS
|
| K-ras mutations and RASSF1A promoter methylation in colorectal cancer.
|
| van Engeland M, Roemen GM, Brink M, Pachen MM, Weijenberg MP, de Bruine AP, Arends JW, van den Brandt PA, de Goeij AF, Herman JG.
|
| Oncogene 21(23):3792-5. 2002
|
| 59 | RASSF1
|
| The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells.
|
| Kuzmin I, Gillespie JW, Protopopov A, Geil L, Dreijerink K, Yang Y, Vocke CD, Duh FM, Zabarovsky E, Minna JD, Rhim JS, Emmert-Buck MR, Linehan WM, Lerman MI.
|
| Cancer Res 62(12):3498-502. 2002
|
| 60 | RASSF1
|
| Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines.
|
| Harada K, Toyooka S, Maitra A, Maruyama R, Toyooka KO, Timmons CF, Tomlinson GE, Mastrangelo D, Hay RJ, Minna JD, Gazdar AF.
|
| Oncogene 21(27):4345-9. 2002
|
| 61 | RASSF1
|
| Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
|
| Schagdarsurengin U, Gimm O, Hoang-Vu C, Dralle H, Pfeifer GP, Dammann R.
|
| Cancer Res 62(13):3698-701. 2002
|
| 62 | RASSF1
|
| Methylation of the RASSF1A gene in human cancers.
|
| Pfeifer GP, Yoon JH, Liu L, Tommasi S, Wilczynski SP, Dammann R.
|
| Biol Chem 383(6):907-14. Review. 2002
|
| 63 | RASSF1
|
| Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.
|
| Hogg RP, Honorio S, Martinez A, Agathanggelou A, Dallol A, Fullwood P, Weichselbaum R, Kuo MJ, Maher ER, Latif F.
|
| Eur J Cancer 38(12):1585-92. 2002
|
| 64 | RASSF1
|
| Frequent hypermethylation of the RASSF1A gene in prostate cancer.
|
| Liu L, Yoon JH, Dammann R, Pfeifer GP.
|
| Oncogene 21(44):6835-40. 2002
|
| 65 | RASSF1
|
| Frequent RASSF1A tumour suppressor gene promoter methylation in Wilms' tumour and colorectal cancer.
|
| Wagner KJ, Cooper WN, Grundy RG, Caldwell G, Jones C, Wadey RB, Morton D, Schofield PN, Reik W, Latif F, Maher ER.
|
| Oncogene 21(47):7277-82. 2002
|
| 66 | RASSF1
|
| Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development.
|
| Lusher ME, Lindsey JC, Latif F, Pearson AD, Ellison DW, Clifford SC.
|
| Cancer Res 62(20):5906-11. 2002
|
| 67 | RASSF1
|
| Frequent loss of chromosome 3p and hypermethylation of RASSF1A in cholangiocarcinoma.
|
| Wong N, Li L, Tsang K, Lai PB, To KF, Johnson PJ.
|
| J Hepatol 37(5):633-9. 2002
|
| 68 | RASSF1
|
| The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis.
|
| Dreijerink K, Braga E, Kuzmin I, Geil L, Duh FM, Angeloni D, Zbar B, Lerman MI, Stanbridge EJ, Minna JD, Protopopov A, Li J, Kashuba V, Klein G, Zabarovsky ER.
|
| Proc Natl Acad Sci U S A 98(13):7504-9. 2001
|
| 69 | RASSF1, DLEC1
|
| Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression.
|
| Burbee DG, Forgacs E, Zochbauer-Muller S, Shivakumar L, Fong K, Gao B, Randle D, Kondo M, Virmani A, Bader S, Sekido Y, Latif F, Milchgrub S, Toyooka S, Gazdar AF, Lerman MI, Zabarovsky E, White M, Minna JD.
|
| J Natl Cancer Inst 93(9):691-9. 2001
|
| 70 | FHIT, RASSF1, ROBO1, VHL
|
| Tumor suppressors on 3p: a neoclassic quartet.
|
| Huebner K.
|
| Proc Natl Acad Sci U S A 98(26):14763-5. No abstract available. 2001
|
| 71 | RASSF1
|
| Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours.
|
| Agathanggelou A, Honorio S, Macartney DP, Martinez A, Dallol A, Rader J, Fullwood P, Chauhan A, Walker R, Shaw JA, Hosoe S, Lerman MI, Minna JD, Maher ER, Latif F.
|
| Oncogene 20(12):1509-18. 2001
|
| 72 | RASSF1
|
| Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers.
|
| Dammann R, Yang G, Pfeifer GP.
|
| Cancer Res 61(7):3105-9. 2001
|
| 73 | RASSF1
|
| Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
|
| Morrissey C, Martinez A, Zatyka M, Agathanggelou A, Honorio S, Astuti D, Morgan NV, Moch H, Richards FM, Kishida T, Yao M, Schraml P, Latif F, Maher ER.
|
| Cancer Res 61(19):7277-81. 2001
|
| 74 | RASSF1, DLEC1
|
| Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.
|
| Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP.
|
| Nat Genet 25(3):315-9. 2000
|
| 75 | RASSF1, DLEC1
|
| Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene.
|
| Sekido Y, et al.
|
| Oncogene 16 : 3151-3157. 1998
|